Assistant Professor, Department of Radiology, UCSF
Phone: (415) 353-9410 (voice)
Box 2520, UCSF
San Francisco, CA 94143-2520
Robert Bok, MD, PhD, is an Assistant Adjunct Professor in the Department of Radiology and Biomedical Imaging and the Hyperpolarized MRI Technology Resource Center at the University of California, San Francisco. Dr. Bok obtained his PhD in Biochemistry from the University of Illinois in 1984, and he earned his MD in Medicine from The Johns Hopkins University, Baltimore in 1989. He completed his residency in Internal Medicine from the University of Minnesota, Minneapolis in 1992, followed by a fellowship in Hematology-Oncology from UCSF in 1996.
At the UCSF Mission Bay Surbeck Laboratory, Dr. Bok provides physician coverage for research on MRI/MRSI scans performed on patients. Dr. Bok’s research activities focuses on the development of better molecular imaging methods for detecting and monitoring prostate cancer. His primary interest is on the use of pre-clinical animal models to improve recent advances in MRSI for prostate cancer. This includes hyperpolarized carbon-13 techniques, high-resolution magic angle spectroscopy, and the use of novel nanoparticles. Dr. Bok and his colleagues are also investigating the use of hyperpolarized 13C-pryuvate in a transgenic mouse model for prostate cancer known as Transgenic Adenocarcinoma of Mouse Prostate (TRAMP).
Dr. Bok is a current member of the American Association of Cancer Research, the Cancer and Leukemia Group B, the UCSF Comprehensive Cancer Center, the Association of North California Oncologists, and the International Society of Magnetic Resonance in Medicine. He has 49 published articles and he has written 53 peer-reviewed articles and 62 abstracts.
Expertise:
Oncology
Specialty:
Prostate cancer, TRAMP, nanoparticles
Professional Interests:
Prostate cancer, urologic oncology, molecular imaging, hyperpolarized carbon-13 spectroscopy, high-resolution magic-angle spin spectroscopy, transgenic cancer models, extracellular proteases, metastases, molecular biomarkers
Education and Training:
• Medical School: The Johns Hopkins University, Baltimore - Medicine
• Internship: University of Minnesota, Minneapolis - Internal Medicine
• Residency: University of Minnesota, Minneapolis - Internal Medicine
• Fellowship: University of California, San Francisco - Hematology-Oncology
• Doctor of Philosophy: University of Illinois, Urbana - Biochemistry
• Medical License, State of California
• ABIM, Board Certification in Internal Medicine
• ABIM, Board Certification in Medical Oncology
• ACLS Certification
Valparaiso University, Valparaiso, IN, B.S., 1980, Biology and Chemistry
University of Illinois, Champaign-Urbana, IL, Ph.D., 1984, Biochemistry
John Hopkins University, Baltimore, MD, M.D., 1989, Medicine
University of Minnesota, Minneapolis, MN, Residency, 1992, Internal Medicine
University of California, San Francisco, Fellow, 1996, Hematology-Oncology
Immunotherapies, Targeted Agents, and More on Horizon in Treatment of TNBC with @hoperugo https://t.co/1X7DhgxwQt via @TargetedOnc
Copyright © 2015-2016 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center
Site Map | Terms of Use & Privacy Policy | Contact Webmaster
